Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi
Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
